ArticleOncology letters2023

Targeting transient receptor potential canonical 1 reduces non‑small cell lung cancer chemoresistance and stemness via inhibition of PI3K/AKT signaling.

Jiahui Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.